title: Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
authors.affiliation: Institute of oncology, Hacettepe University, Hacettepe, Ankara, Turkey.
authors.forename: E
authors.initials: E
authors.lastname: Kansu
authors.forename: Y
authors.initials: Y
authors.lastname: Koc
authors.forename: A
authors.initials: A
authors.lastname: Kars
authors.forename: M
authors.initials: M
authors.lastname: Alakavuklar
authors.forename: G
authors.initials: G
authors.lastname: Tekuzman
authors.forename: D
authors.initials: D
authors.lastname: Firat
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006801:Humans; D007262:Infusions, Intravenous; D007938:Leukemia / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000473:pathology; D008942:Mitoxantrone / Q000008:administration & dosage; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D003561:Cytarabine; D008942:Mitoxantrone